PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer

Background: The polypyrimidine tract-binding protein (PTBP) nuclear ribonucleoprotein family of proteins, including PTBP1, PTBP2 and PTBP3, regulate the process of cell proliferation, differentiation, apoptosis and carcinogenesis. PTBPs exhibit oncogenic effects in certain tumors. However, the role...

Full description

Bibliographic Details
Main Authors:	Chen Chen, Anquan Shang, Yuting Gao, Jingjuan Huang, Gege Liu, William C. Cho, Dong Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Molecular Biosciences
Subjects:	biomarkers immunotherapy pan-cancer polypyrimidine tract-binding proteins prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.968458/full

Similar Items

Polypyrimidine tract binding protein knockdown reverses depression-like behaviors and cognition impairment in mice with lesioned cholinergic neurons
by: Yiying Zhou, et al.
Published: (2023-04-01)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
by: Pan Xie, et al.
Published: (2022-08-01)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
by: Jian Ding, et al.
Published: (2022-05-01)

CISD3 is a prognostic biomarker and therapeutic target in pan-cancer
by: Jie Li, et al.
Published: (2024-10-01)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
by: Boyu Pan, et al.
Published: (2023-06-01)

A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01)

Prognostic value of TMTC1 in pan-cancer analysis
by: Ying Zhang, et al.
Published: (2024-10-01)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
by: Mohamed A. Soltan, et al.
Published: (2023-03-01)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
by: Wenqing Zhang, et al.
Published: (2023-01-01)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
by: Kejun Liu, et al.
Published: (2022-08-01)

Pan-cancer analysis of Sp1 with a focus on immunomodulatory roles in gastric cancer
by: Yang Zhou, et al.
Published: (2024-10-01)

A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma
by: Pouria Samadi, et al.
Published: (2023-12-01)

Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response
by: Shengshan Xu, et al.
Published: (2024-08-01)

Integrative and comprehensive pan-cancer analysis of ubiquitin specific peptidase 11 (USP11) as a prognostic and immunological biomarker
by: Lijuan Cui, et al.
Published: (2024-07-01)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
by: Chen Xiao, et al.
Published: (2022-08-01)

Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan-cancer analysis
by: Fatemeh Maghool, et al.
Published: (2024-11-01)

ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis
by: Yuan Lin, et al.
Published: (2023-03-01)

Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer
by: Quan Chen, et al.
Published: (2024-04-01)

Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer
by: Enzhi Yin, et al.
Published: (2024-11-01)

Insights into the prognostic value and immunological role of CD74 in pan-cancer
by: Zebiao Liu, et al.
Published: (2024-06-01)

Prognostic and immunological role of SERPINH1 in pan-cancer
by: Huage Zhong, et al.
Published: (2022-08-01)

Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors
by: Tianrui Kuang, et al.
Published: (2024-02-01)

Pan-cancer analysis shows that BCAP31 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types
by: Yangyong Sun, et al.
Published: (2024-12-01)

EBNA1BP2 identified as potential prognostic biomarker for multiple tumor types in pan-cancer analysis
by: Li-Yue Sun, et al.
Published: (2024-10-01)

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
by: Gujie Wu, et al.
Published: (2022-07-01)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
by: Bo Ma, et al.
Published: (2023-04-01)

The epiphany derived from T-cell–inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responses
by: Decao Niu, et al.
Published: (2022-08-01)

CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis
by: Yanchun Huang, et al.
Published: (2023-07-01)

Pan-cancer and single-cell analysis reveal THRAP3 as a prognostic and immunological biomarker for multiple cancer types
by: Ye-Peng Wang, et al.
Published: (2024-01-01)

Pan-cancer identified ARPC1B as a promising target for tumor immunotherapy and prognostic biomarker, particularly in READ
by: Chenxiong Zhang, et al.
Published: (2024-04-01)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
by: Zihua Li, et al.
Published: (2022-04-01)

Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2
by: Huidong Feng, et al.
Published: (2023-07-01)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
by: Shan Jiang, et al.
Published: (2023-09-01)

The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis
by: Yang S, et al.
Published: (2025-03-01)

Pan-immune-inflammation value as a novel prognostic biomarker for digestive system cancers: a meta-analysis
by: Dongli Yu, et al.
Published: (2024-11-01)

Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
by: Peiyi Xu, et al.
Published: (2024-12-01)

PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer
by: Ruijun Zhao, et al.
Published: (2023-10-01)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
by: Hengli Zhou, et al.
Published: (2023-04-01)

Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor types
by: Hong-Lu Zhou, et al.
Published: (2024-01-01)